Question explored with the scientific record
Has prickly pear cactus been tested head to head against semaglutide for weight loss?
No. Prickly pear has never been tested head to head against semaglutide for weight loss. The question has no trial behind it.
The retrieval surfaced no such comparison. It did surface rat data: a dehydrated prickly pear extract, Cacti-Nea, cut weight gain in rats (36.2 g vs 43.7 g in controls), a difference that did not reach significance (p = 0.06) [2]. That is an animal study with 6 rats per group. It is not a weight-loss trial, and it says nothing about humans or about semaglutide.
The semaglutide side is real and large. In the STEP program, weekly semaglutide 2.4 mg produced a mean 14.9% weight loss versus 2.4% on placebo in STEP 1 [5], and 13.88% versus 0.42% in a smaller trial of clozapine-treated adults with obesity [4]. Those are randomized comparisons against placebo, not against cactus. The semaglutide trials were industry-run and used weight as the endpoint, not death or hospitalization [5][6].
| Arm | Weight change | Source |
|---|---|---|
| Semaglutide 2.4 mg, STEP 1 | -14.9% | [5] |
| Placebo, STEP 1 | -2.4% | [5] |
| Prickly pear extract, rats | -7.5 g vs control | [2] |
| Control rats | +43.7 g gained | [2] |
One search cannot prove no head-to-head trial exists anywhere. But nothing here even hints at one, and the cactus literature is about extraction chemistry, antioxidants, and rat diuretics [1][3][2], not human weight loss.
My call: no head-to-head trial exists in anything retrieved, and the rat data cannot compete with a 15% human weight loss on semaglutide. Confidence: moderate that no such trial exists; high that cactus is not a tested rival to semaglutide.
Sources used 6
-
Modeling and optimization of betalain extraction from Opuntia ficus-indica using Box–Behnken design with desirability function
This study optimized the extraction of betalains from prickly pear (Opuntia ficus-indica) using Box-Behnken design and numerical optimization, identifying optimal conditions of 42°C, 115 minutes, 1.2 g mass, and pH 6.9 for maximum pigment yield.
DOI: 10.1016/j.indcrop.2013.05.012 -
Diuretic and antioxidant effects of Cacti‐Nea ® , a dehydrated water extract from prickly pear fruit, in rats
This study shows that Cacti-Nea®, a dehydrated water extract from Opuntia ficus-indica prickly pear fruit, acts as a chronic diuretic and antioxidant in rats, increasing glutathione peroxidase activity and elevating urine output to a level comparable to hydrochlorothiazide, with…
DOI: 10.1002/ptr.2996 -
Opuntia (Cactaceae) plant compounds, biological activities and prospects – A comprehensive review
This comprehensive 2018 review synthesizes the phytochemical composition, biological activities, processing effects, by-product valorisation, and potential industrial/nutraceutical applications of Opuntia (prickly pear) plant compounds across its flowers, cladodes, seeds, peel/s…
DOI: 10.1016/j.foodres.2018.06.047 -
206. EFFECTS OF SEMAGLUTIDE ON BODY WEIGHT IN CLOZAPINE-TREATED INDIVIDUALS WITH SCHIZOPHRENIA AND OBESITY: A RANDOMIZED CONTROLLED TRIAL
In a randomized controlled trial, semaglutide led to a 13.88% body weight reduction versus 0.42% with placebo in clozapine-treated adults with schizophrenia and obesity, without significant effects on psychotic symptoms or clozapine levels.
DOI: 10.1093/ijnp/pyaf052.020 -
Wegovy (Semaglutide): A New Weight Loss Drug for Chronic Weight Management
A narrative review synthesizing semaglutide’s weight-loss evidence across the SUSTAIN, PIONEER, and STEP randomized trials (subcutaneous and oral forms) in adults with overweight/obesity, with or without type 2 diabetes, highlighting efficacy, safety, and clinical implications f…
DOI: 10.1136/jim-2021-001952 -
Long Term Management of Obesity with Once Weekly Semaglutide Efficacy and Safety in Clinical Trials
Weekly semaglutide 2.4 mg yields substantial, durable weight loss in adults with overweight/obesity across STEP trials, with gastrointestinal adverse events as the main safety signal.
DOI: 10.52768/2995-5874/1029